Clinical Trial Update: Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques [Phase 4]

View source ↗

Summary

Phase 4 trial comparing nebivolol to atenolol assesses effects on wall shear stress and rupture-prone coronary plaques in atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Endothelial Dysfunction

Drugs mentioned

• Atenolol (Tenormin) (atenolol)
• Nebivolol (Bystolic) (nebivolol)

Snippet

Sponsor: Emory University | Conditions: Atherosclerosis, Endothelial Function | Phase 4 | Status: COMPLETED | Results posted: 2015-02-27